by GlobeNewsWire | Dec 10, 2017 | Globe Newswire
CAMBRIDGE, Mass., Dec. 10, 2017 (GLOBE NEWSWIRE) — Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company developing novel epigenetic therapies, today announced that two presentations reinforcing its commitment to identifying predictors of...
by GlobeNewsWire | Dec 10, 2017 | Globe Newswire
TORONTO, Dec. 10, 2017 (GLOBE NEWSWIRE) — The Fraser Institute’s Report Card on Ontario’s Elementary Schools—now in its 15th year—is out today. This year’s Report Card—the go-to source for measuring academic performance—ranks more than 3,000 anglophone and...